Clinical Lab Manager - News, Editorial and Products for the Clinical Laboratory
CDC Media Statement: CDC Statement Following ACIP Pfizer-BioNTech Vote

CDC Media Statement: CDC Statement Following ACIP Pfizer-BioNTech Vote

CDC endorsed the ACIP recommendation for use of the Pfizer-BioNTech’s licensed vaccine for people 16 and older

Today, CDC Director Rochelle P. Walensky, MD, MPH, endorsed the CDC Advisory Committee on Immunization Practices’ (ACIP) recommendation for use of the Pfizer-BioNTech’s licensed vaccine for people 16 and older.

This recommendation follows FDA’s decision to fully approve Pfizer’s COVID-19 vaccine.

The ACIP recommendation comes nine months after the committee’s interim recommendation and after an exhaustive review of the scientific evidence demonstrating safety and effectiveness, and supporting continued use of the vaccine.

“We now have a fully approved COVID-19 vaccine and ACIP has added its recommendation. If you have been waiting for this approval before getting the vaccine, now is the time to get vaccinated and join the more than 173 million Americans who are already fully vaccinated,” said Walensky.

- This press release was originally published on the Centers for Disease Control and Prevention website